Search This Blog

Monday, September 23, 2019

FDA OKs Medtronic next-gen TAVR system

The FDA approves Medtronic’s (NYSE:MDT) Evolut PRO+ Transcather Aortic Valve Replacement (TAVR) System that features four valve sizes and an external pericardial tissue wrap for advanced sealing.
U.S. commercial launch is underway.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)